The aim of this work is to describe the state of progress of a study developed in the framework of AIM (Artificial Intelligence in Medicine). It is a project funded by INFN, Italy, and it involves researchers from INFN, Hospital Meyer and Radiotherapy Unit of University of Florence. The aim of the proposed study is to apply a retrospective exploratory MR-CT-based radiomics and dosiomic analysis based on emerging machine-learning technologies, to investigate imaging biomarkers of clinical outcomes in paediatric patients affected by medulloblastoma, from images. Features from MR-CT scans will be associated with overall survival, recurrence-free survival, and loco-regional recurrence-free survival after intensity modulated radiotherapy. Dosimetric analysis data will be integrated with the objective of increase predictive value. This approach could have a large impact for precision medicine, as radiomic biomarkers are non-invasive and can be applied to imaging data that are already acquired in clinical settings.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
|Titolo:||Radiomic and dosiomic profiling of paediatric medulloblastoma tumours treated with intensity modulated radiation therapy|
|Data di pubblicazione:||2019|
|Appare nelle tipologie:||4.1 Contributo in Atti di convegno|